Tower Research Capital LLC (TRC) - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$32
-85.0%
7,604
-78.6%
0.00%
-88.9%
Q4 2022$213
-99.6%
35,456
+282.2%
0.01%
+800.0%
Q3 2022$54,000
-64.9%
9,276
-64.2%
0.00%
-66.7%
Q2 2022$154,000
+156.7%
25,919
+102.6%
0.00%
+200.0%
Q1 2022$60,000
+1.7%
12,792
-45.8%
0.00%0.0%
Q4 2021$59,000
+490.0%
23,586
+630.2%
0.00%
Q3 2021$10,000
-87.0%
3,230
-86.5%
0.00%
-100.0%
Q4 2020$77,000
+220.8%
23,865
+110.6%
0.00%
Q3 2020$24,00011,330
+2656.7%
0.00%
Q2 2020$0
-100.0%
411
-83.9%
0.00%
Q4 2019$4,000
-73.3%
2,554
-85.4%
0.00%
-100.0%
Q2 2019$15,000
+400.0%
17,495
+563.4%
0.00%
Q1 2019$3,000
-76.9%
2,637
-84.9%
0.00%
-100.0%
Q4 2018$13,000
+44.4%
17,434
+318.3%
0.00%0.0%
Q3 2018$9,000
-86.6%
4,168
-69.2%
0.00%
-75.0%
Q2 2018$67,000
+204.5%
13,530
+137.2%
0.00%
+100.0%
Q1 2018$22,000
+69.2%
5,705
+35.9%
0.00%
+100.0%
Q3 2017$13,0004,199
+2899.3%
0.00%
Q2 2017$0
-100.0%
140
-89.9%
0.00%
-100.0%
Q1 2017$6,0001,3920.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders